Developing innovative solutions in the area of Interventional Oncology

Our proprietary products help provide novel targeted therapies for local drug-delivery across a broad range of solid cancers.

About Us

We are developing technologies to enable targeted delivery of chemotherapy.

Isovasc Medical, a privately owned medical device company focused on unmet clinical needs for patients with solid cancers, specializes in Vascular Access with AVAS® (CE marked device and TGA approved) and Isolated Perfusion with the Stopflow Occlusion Catheter.*

*The Stopflow Occlusion Catheter is an investigational product, it is intended solely for investigational research use at this time.

AVAS® The Arterial Vascular Access System

An implantable vascular access device, intended to facilitate repeatable simultaneous multi-catheter peripheral arterial vascular access.

CE Mark AVAS® has received CE Mark approval in Europe and TGA approval in Australia.
Learn more
AVAS System
Stopflow
The Stopflow Occlusion Catheter*

A three-lumen balloon catheter specifically developed for use in both the arterial and venous vasculature that may be used in performing regional chemotherapy, thereby enabling targeted delivery of a therapeutic agent(s) directly to an organ or specific area of the body, which is isolated by means of balloon occlusion.

*The Stopflow Occlusion Catheter is an investigational product, it is intended solely for investigational research use at this time.

Learn more